Synfini, is revolutionizing small molecule drug discovery with its AI Cloud Foundry-a platform that integrates artificial intelligence, chemistry automation, and cloud-native workflows to generate better molecules, faster. Founded by domain experts in synthetic chemistry, machine learning, and drug development, Synfini partners with biotech and pharmaceutical companies to bring forward breakthrough therapies with greater speed and precision.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/07/25 | $8,900,000 |
JSL Health Capital | undisclosed |
